Compare SPCE & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCE | CBUS |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.3M | 69.9M |
| IPO Year | N/A | 2017 |
| Metric | SPCE | CBUS |
|---|---|---|
| Price | $3.21 | $1.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $9.22 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 5.0M | 299.6K |
| Earning Date | 02-25-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,661,000.00 | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,702.45 | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $1.09 |
| 52 Week High | $6.64 | $3.40 |
| Indicator | SPCE | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 47.42 | 43.18 |
| Support Level | $2.87 | $1.46 |
| Resistance Level | $3.32 | $2.04 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 66.67 | 9.82 |
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.